AB
RCKT icon

Amalgamated Bank’s Rocket Pharmaceuticals RCKT Stock Holding History

Amalgamated Bank’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,662
Closed -$9K – 2549
2025
Q4 		$9K Buy
2,662
+5
+0.2% +$17 ﹤0.01% 2486
2025
Q3 		$9K Hold
2,657
– – ﹤0.01% 2527
2025
Q2 		$7K Hold
2,657
– – ﹤0.01% 2602
2025
Q1 		$18K Buy
2,657
+517
+24% +$5.11K ﹤0.01% 2104
2024
Q4 		$27K Hold
2,140
– – ﹤0.01% 2018
2024
Q3 		$40K Hold
2,140
– – ﹤0.01% 1907
2024
Q2 		$46K Hold
2,140
– – ﹤0.01% 1870
2024
Q1 		$58K Sell
2,140
-6,513
-75% -$185K ﹤0.01% 1829
2023
Q4 		$259K Buy
8,653
+440
+5% +$9.71K ﹤0.01% 1717
2023
Q3 		$168K Hold
8,213
– – ﹤0.01% 1841
2023
Q2 		$163K Buy
8,213
+2,434
+42% +$49.2K ﹤0.01% 1897
2023
Q1 		$99K Sell
5,779
-1,285
-18% -$25.2K ﹤0.01% 2064
2022
Q4 		$138K Buy
7,064
+1,503
+27% +$27.7K ﹤0.01% 1997
2022
Q3 		$89K Hold
5,561
– – ﹤0.01% 2204
2022
Q2 		$77K Sell
5,561
-1,150
-17% -$13.7K ﹤0.01% 2286
2022
Q1 		$106K Buy
+6,711
New +$116K ﹤0.01% 2175
2021
Q4 		– Sell
-7,238
Closed -$216K – 2174
2021
Q3 		$216K Sell
7,238
-264
-4% -$9.61K ﹤0.01% 1967
2021
Q2 		$332K Buy
7,502
+2,179
+41% +$94.6K ﹤0.01% 1838
2021
Q1 		$236K Buy
5,323
+1
+0% +$55 0.01% 1396
2020
Q4 		$292K Buy
+5,322
New +$194K 0.01% 1240

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Amalgamated Bank's RCKT Position: Q1 2026 in Review

Amalgamated Bank sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 2,662 shares — an estimated $9K sold.

Amalgamated Bank first reported a position in RCKT in Q4 2020 and held it in 20 quarters. The position peaked at $332K in Q2 2021. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Amalgamated Bank reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,662 Rocket Pharmaceuticals shares in Q1 2026, an estimated $9K.
  • Amalgamated Bank first reported a position in Rocket Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Amalgamated Bank's Rocket Pharmaceuticals position peaked at $332K in Q2 2021.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.